the expression of a panel of podocyte essential proteins (nephrin, podocin and CD2-associated protein or CD2AP) and changes transepithelial albumin flux. These effects are dsRNA sensor-specific: TLR3-/-podocytes do not respond to extracellular dsRNA, while intracellular dsRNA has no effect on podocytes bearing a dominant negative form of the major active RLH. These results demonstrate that innate responses to viruses can disturb podocyte cell function in vitro.
RNA (dsRNA). Most viral pathogens for mammals produce dsRNA incidental to viral replication. Membranebound Toll-like receptor 3 (TLR3) and a family of cytosolic helicases bind to dsRNA. As the first recognized cytosolic sensor for dsRNA, retinoic acid-inducible gene 1 (RIG-I) lent its name to the family of helicases, termed RIG-I-like helicases (RLHs); LGP2 are the only other known RLHs at present [5] . Depending on cell lineage, TLR3 is present mainly on endosomal membrane, but also on plasma membrane in some types of cells. Whereas TLR3 binds primarily to dsRNA either after endocytosis or in extracellular fluids, RLHs recognize cytoplasmic dsRNA. Importantly, both dsRNA sensors eventually induce antiviral and inflammatory responses primarily through the activation of two transcription factors, interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-B) [6, 7] . Some forms of glomerulonephritis, i.e. inflammation of the filtering apparatus in kidneys, are associated with viral infection. Notably, immunoglobulin A nephropathy (IgAN), the most common form of glomerulonephritis throughout the world, develops and is exacerbated in close temporal association with viral infections. Glomerulonephritis is a recognized consequence of hepatitis C infection; glomerulonephritis instigated by hepatitis B or by systemic lupus erythematosus or other autoimmune diseases might also be caused or intensified by innate responses to viruses [8] . On the other hand, the glomerulopathy instigated by human immunodeficiency virus I is induced by the cytopathic effects of proteins produced by the retrovirus and is unrelated to viral replication. Notably, the onset and episodic flares of clinical IgAN and the derangements in glomerular function in a murine model of IgAN induced by immunization and challenge with murine paramyxovirus are closely related to viral replication. We hypothesized that glomerular dysfunction arises from synergy between the glomerular deposition of immune complexes and innate responses to viral replication. We focused on dsRNA because this PAMP depends upon replication of, rather than simply the presence of a virus.
In patients with IgAN, proteinuria, excretion of protein in the urine is an important predictor of the course of disease and a marker for response to therapy. Proteinuria is also an index of the severity of glomerulonephritis in animal models. Visceral glomerular epithelial cells, those that line the glomerular capillary tufts at the interface with the urinary (Bowman's) space, have become well recognized as a determinant of glomerular permselectivity. These cells, also known as podocytes, are highly specialized epithelial cells that extend a series of actinrich projections known as foot processes, which interdigitate to form a sheath around the glomerular capillaries. A highly organized multiprotein complex formed between juxtaposed foot processes establishes a distinct porous cell junction known as the slit diaphragm serves as the final sieve of the glomerular filter [9] . Injury to or loss of podocytes causes proteinuria.
Accordingly, we investigated the innate responses of podocytes to dsRNA, reasoning that such responses might contribute to glomerular dysfunction, and especially to proteinuria, in glomerulonephritis associated with viral infection. We report that TLR3 and RLH signalings in podocytes lead to structural and functional changes that might influence glomerular permeability to serum proteins and/or glomerular response to injury instigated by immune complexes. These observations might elucidate the molecular mechanisms operative in glomerulonephritis, especially those associated with viral infection, and might ultimately offer novel strategies for therapy of these diseases.
Materials and Methods

Cell Cultures and Stimuli
Wild-type murine podocytes, a generous gift from Dr. Peter Mundel (Boston, Mass., USA), and TLR3-/-podocytes, generated from TLR3-/-'immorto-mice' [10, 11] , were propagated on collagen I-coated dishes at 33 ° C (permissive temperature) in RPMI supplemented with 10% FBS and 10 U/ml of recombinant mouse IFN-␥ (Invitrogen). Murine podocytes expressing RIG-Ic, a dominant negative form of RIG-I, were generated by transfection with pBos-Flag-RIG-Ic (a generous gift from Dr. Takashi Fujita, University of Kyoto, Kyoto, Japan) and pBABE-puro (Addgene, Cambridge, Mass., USA) selected by puromycin (1 g/ml). RIG-Ic expression was confirmed by Western blot with Flag antibody (Sigma, St. Louis, Mo., USA). To induce differentiation, the medium was changed to RPMI with 10% FBS without IFN-␥ , and the cells were shifted to 37 ° C (nonpermissive temperature) for 7-14 days. Under these conditions, cells underwent growth arrest, increased in size, and developed elongated cell processes. Immortalized human podocytes, generously provided by Dr. Moin Saleem (University of Bristol, Bristol, UK) through Dr. Jeffrey Kopp (NIH, Bethesda, Md., USA), were cultured as described previously [12] and used for experiments under permissive conditions. Mouse embryonic fibroblasts (MEFs), either wild-type or lacking TLR3, TRIF, IRF3, RIG-I, Mda-5, IPS-1 or TBK-1, Raw 264.7, and human fibrosarcoma HT1080 cells were all maintained in DMEM supplemented with 10% FBS (Atlanta Biologicals, Lawrenceville, Ga., USA), 100 U/ml penicillin and 100 g/ml streptomycin [13, 14] . Polyinosinic-polycytidylic acid [Poly(I:C)], a synthetic dsRNA, was purchased from GE Healthcare (Piscataway, N.J., USA), and FuGENE 6 was obtained from Roche Applied Science (Indianapolis, Ind., USA). Staurosporine was purchased from Sig-ma and was used at 1 M . Sendai virus (SeV) was obtained from ATCC (Manassas, Va., USA) and used at a multiplicity of infection (MOI) of 10.
RT-PCR and Immunoblotting
RT-PCR was performed as previously described [15] , with various primer pairs ( table 1 ) . Amplified bands were separated on agarose gels and detected with ethidium bromide. As detailed elsewhere [13] , for immunoblotting, cells were subjected to lysis in a buffer (150 m M NaCl, 20 m M HEPES [pH 7.4], 1.5 m M MgCl 2 , 2 m M DTT, 2 m M EGTA, 10 m M NaF, 12.5 m M ␤ -glycerophosphate and 1 m M Na 3 VO 4 ) supplemented with complete EDTA-free protease inhibitor (Roche Applied Science) with 0.5% (v/v) Triton X-100. Cytosolic and nuclear fractions of cellular proteins were isolated by procedures described earlier [14] . After separation on PAGE gels, proteins were transferred to PDVF membranes. The blots were incubated with antibodies specific for mouse or human TLR3 (Abcam, Cambridge, Mass. and IMGENEX, San Diego, Cal if., USA, respectively), P54, P56, P60 (generated in our lab), IRF3 (Invitrogen, Camarillo, Calif., USA), pS 396 IRF3 and cleaved PARP (Cell Signaling Technology, Danvers, Mass., USA), NF-B P65 (Santa Cruz, Calif., USA), pS 32 
Plasmid Construct and Recombinant Protein
The plasmid encoding the cytoplasmic domain of human TLR3 (CTD, AA726-904, Swiss-Prot: O15455) was generated by PCR amplification using full-length TLR3 as a template and cloned into pHis parallel vector (Roche). Escherichia coli BL21(DE3) cells were transformed with pHis parallel vectors. TLR3-CTD was induced by 1 m M isopropyl ␤ -D-thiogalactopyranoside (IPTG) for 8 h at 30 ° C. Protein purification was achieved using Ni-NTA superflow beads (Qiagen) as described previously [16] .
Immunocytochemistry and ELISA
Human or murine podocytes were cultured on type I collagencoated coverslips for 7-10 days under nonpermissive condition. Cells were fixed with 3% paraformaldehyde in PBS for 20 min at room temperature, were rinsed 3 times with PBS, and then permeabilized by incubating with 100% methanol for 5 min. Cells were again rinsed 3 times with PBS and then blocked with 10% goat serum in PBS for 1 h. Cells were incubated with the primary antibodies against human or murine TLR3 (Abcam or IM-GENEX, respectively), IRF3 (Invitrogen) or NF-B P65 (Santa Cruz) overnight at 4 ° C. After washing 3 times with PBS, cells were incubated with the Alexa 488-labeled appropriate secondary antibody (Invitrogen) for 1 h at room temperature. Cells were again rinsed 3 times with PBS, mounted using mounting medium and then visualized using a fluorescent microscope. To detect interleukin (IL)-8 protein in culture supernatants, we employed a commercial ELISA kit (human IL-8 DuoSet; R&D Systems, Minneapolis, Minn., USA), following the manufacturer's instructions.
Wound Healing Assay
The wound healing assay has been described elsewhere [13] . Briefly, podocytes were grown on type I collagen-coated 6-well plates for 7-10 days to be differentiated. Wounds were created by scratching the monolayer with the tip of a micropipette. After the cells were washed with warm media, they were maintained in regular media with 10% FBS, with or without stimulus, for 24 h. To analyze cell migration, the same area of the culture surface was photographed at 0 h and the end of the incubation time. Cells migrating into the defect were enumerated in at least 8 fields for each condition, and normalized to the number of migrating cells without any stimulation (defined as 100%).
Transepithelial Albumin Flux
To evaluate the filtration barrier function of podocytes [17, 18] , differentiated human podocytes were incubated in growth-permissive conditions (as above), then split at 95% confluence and seeded onto 5.0-m Transwell permeable supports (CoSTART, Corning, N.Y., USA) with RPMI (no phenol red) containing 10% FBS. The basolateral chamber was supplemented with 500 g/ml of bovine serum albumin conjugated to fluorescein (Invitrogen). Triplicate wells were incubated at 37 ° C with or without stimulation. At selected times, a 50-l aliquot of apical medium was transferred to a clean well in a 96-well assay plate (BD Falcon Optiflux black/clear bottom plates), and replaced with fresh prewarmed medium. The fluorescent albumin concentration in each well at each time point was read on a Victor Fluorescence Multiplate Reader (Perkin Elmer).
Statistics
Statistical analyses were performed using Prism 5 (GraphPad Software, La Jolla, Calif., USA). Error bars represent SEM, and differences were analyzed using ANOVA with the Bonferroni post hoc test. [19] . By immunocytochemistry, human podocytes exhibited a punctate pattern of staining for TLR3 throughout the cytoplasm but predominantly in the perinuclear areas ( fig. 2 a, left panel), which is suggestive of localization within endosomes. Like TLR3, murine podocytes as well as human podocytes express RIG-I and IPS-1 proteins, as detected by Western blot ( fig. 2 b, c) . The cell lysates were probed by Western blot for human P56 and P60. b Podocytes from TLR3-/-mice were left unstimulated (-) or treated by adding (TLR3) or transfecting (RLH) Poly(I:C); after 8 h, cell lysates were tested for mouse P54 by Western blot. c Human podocytes were stimulated by adding varying concentrations (0-100 g/ml) of Poly(I:C) as indicated for 8 h; blots from cell lysates were probed for P56 or P60. d Human podocytes were stimulated by adding 50 g/ml Poly(I:C) for varying incubation times (0-24 h), as indicated; blots were stained for P56 or P60. Immunoblotting for actin served as a loading control for all Western blots. e Human podocytes, grown on coverslips, were left unstimulated (-) or stimulated by transfection with (RLH) or addition of (TLR3) Poly(I:C) for 3 h, as above. Cells were then stained with anti-IRF3 Ab. f Mouse podocytes were grown on coverslips and left untreated (-) or transfected (RLH) or added (TLR3) Poly(I:C) for 3 h, as above and stained with anti-IRF3 Ab. g Cytosolic (CP) or nuclear (Nuc) proteins fractionated from human podocytes were collected 3 h after no addition of dsRNA (-) or after RLH or TLR3 stimulation. IRF3 in the fractions was detected by Western blot. The membranes were also probed for DRBP76 and tubulin as markers for nuclear and cytoplasmic proteins, respectively. h Phosphorylation of IRF3 at serine 396 (pS 396 IRF3) was tested by Western blots applied to lysates from human podocytes left untreated or stimulated for 3 h by RLH or TLR3 ligands (as above). Immunostains for total IRF3 and actin were used as loading controls.
Results
TLR3 and RLH Signaling Molecules in Murine and Human Podocytes
IRF3 Pathway Activation by TLR3 or RLH Stimulation
To determine whether TLR3 and RLH function to transmit intracellular signals in podocytes, we examined the expression of P54, P56 and P60. Synthesis of these proteins is driven by IRF3 as a common transcription factor [4] . Stimulation by TLR3 or RLH agonists strongly induced P56 and P60 in human podocytes after 8 h ( fig. 3 a) . Mouse podocytes with a homozygous deletion of TLR3 (TLR3-/-) produced P54 in response to RLH stimulation, but not in response to TLR3 stimulation ( fig. 3 b) . Addition of as little as 1 g/ml of extracellular dsRNA to human podocytes induced P56 and P60 (via TLR3) by 8 h ( fig. 3 c) , and 50 g/ml of extracellular dsRNA elicited P56 and P60 protein after 4 or 16 h, respectively ( fig. 3 d) .
The transcription factor IRF3 can be activated by either TLR3 or RLH stimulation. In both human ( fig. 3 e) and murine ( fig. 3 f) podocytes, IRF3 was translocated into the nucleus in response to either RLH or TLR3 stimulation (middle or right panels, respectively); in unstimulated cells, IRF3 is localized mainly in the cytoplasm (left panels). In human podocytes, IRF3 was present in nuclear as well as cytosolic fractions within 3 h after RLH or TLR3 stimulation, but was confined to the cytosolic fraction in the unstimulated cells ( fig. 3 g ). Transcriptional activation of gene products driven by IRF3 requires phosphorylation of IRF3 at serine 396 [14] . After stimulation via RLH or TLR3 for 3 h, IRF3 phosphorylated at serine 396 was readily detected in human podocytes, whereas the phosphorylated form was not detected in the unstimulated cells ( fig. 3 h ). These data demonstrate that the IRF3 pathway in podocytes is activated by TLR3 or RLH signaling.
NF-B Pathway Activation by TLR3 or RLH Stimulation
In addition to IRF3, NF-B is a major transcription factor that regulates inflammatory responses to TLR3 and RLH signaling. After 24 h, culture supernatants from human podocytes contained double or triple the amount of the chemokine IL-8, 24 h after transfection with (RLH stimulation) or extracellular addition of (TLR3 stimulation) dsRNA ( fig. 4 a) . Likewise, the regulatory protein A20 was upregulated in human podocytes after 8 h of RLH or TLR3 stimulation ( fig. 4 b) . Synthesis of these proteins, among others, is driven by the activation of NF-B. To assess activation of NF-B directly, we examined NF-B P65 nuclear translocation in human and murine podocytes by immunocytochemistry. Both human podocytes ( fig. 4 c) and murine podocytes ( fig. 4 d) translocated P65 to the nucleus within 3 h of RLH or TLR3 stimulation. Furthermore, whereas P65 was confined to the cytosol in the unstimulated human podocytes, stimulation via RLH or TLR3 promoted accumulation of P65 in the nuclear fraction ( fig. 4 e) . Finally, IkB ␣ , the regulatory inhibitor of NF-B, was phosphorylated at serine 32 in human podocytes within 3 h of RLH or TLR3 stimulation ( fig. 4 f) . This phosphorylation leads to proteasomal degradation of I B ␣ , releasing P65 for heterodimer formation and nuclear translocation. Thus, functional activation of NF-B occurs in podocytes after TLR3 and RLH ligation.
Innate Responses to Viral Infection Disturb Cell Migration of Podocytes
Cell migration is a complex and highly regulated cellular function that is important in a wide variety of physiological and pathologic conditions [20] [21] [22] . To evaluate the functional effects of innate podocyte responses to viruses, we measured cell migration in a wound-healing assay. Stimulation of wild-type murine podocytes by transfection with (via RLH signaling) or the addition of (via TLR3 signaling) dsRNA strongly suppressed migration of cells into a standardized defect introduced into the culture monolayer ( fig. 5 a, left) . In contrast to RLH signaling, TLR3 stimulation by 2 g/ml of Poly(I:C) was not enough to induce the cell migration effect or expression of the IRF3-dependent gene product, P56 ( fig. 5 a, right) . 
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The suppressed cell migration was not due to cell death by dsRNA stimulation; cell monolayers appeared intact ( fig. 5 b, left panel) and did not exhibit cleavage of PARP, a marker of apoptotic cells ( fig. 5 b, right panel) . As expected, treatment with staurospoine (1 M ), a strong inducer of mitochondrial dysfunction, triggered rapid, morphologically evident cell death and the generation of cleaved PARP in murine podocytes ( fig. 5 b) . Addition of, but not transfection with, dsRNA suppressed wound healing in murine podocytes that bore a dominant negative RIG-I construct and were therefore defective in RLH signaling ( fig. 5 c) . Reciprocally, transfected, but not added, dsRNA suppressed wound healing in TLR3-/-murine podocytes ( fig. 5 d) . These data indicate that either cytosolic or extracellular dsRNA, dependent on RLH or TLR3 signaling, respectively, exerts significant effects on podocyte function. Likewise, infection of wild-type murine podocytes by SeV leads to defective wound healing ( fig. 5 e) , without triggering cell death ( fig. 5 b) .
TLR3 or RLH Activation Alters the Expression Levels of Podocyte-Specific Proteins and Changes Transepithelial Albumin Flux
Nephrin, podocin and CD2AP are proteins that are widely recognized as essential for podocyte function. Mutation of any of these molecules causes nephrotic syndrome, leading to end-stage renal failure, and the level of these proteins is altered in a variety of glomerular diseases [23] [24] [25] . To ascertain if innate responses to viruses influence the expression of these molecules, we performed Western blotting on lysates from podocytes. RLH stimulation decreased nephrin and podocin expression within 24 h and strongly increased CD2AP levels within 8 h ( fig. 6 a) . On the other hand, TLR3 stimulation of human podocytes had decreased CD2AP after 8 h and nephrin and podocin expression after 24 h ( fig. 6 b) . Although dsRNA represents a surrogate of virus infection, the subsequent outcomes vary with virus and cell types. We therefore tested the expression of podocyte marker proteins after viral infection. The murine paramyxovirus SeV downregulated the expression of nephrin and podocin in both human ( fig. 6 c) and murine ( fig. 6 d) podocytes, but increased the expression of CD2AP. Taken together, innate immune responses to dsRNA or SeV infection perturbs expression of proteins that are specific to and functionally important for podocytes.
Monolayers of differentiated podocytes cultured on cell well inserts polarize, form the organized junctions observed in vivo and restrict the flux of macromolecules between basolateral and apical surfaces. Transcellular macromolecular flux across podocyte monolayers has been employed as an in vitro homologue to proteinuria [17, 18] . Therefore, in addition to assessment of the in vitro wound healing and expression of the proteins intrinsic to the slit diaphragm ( fig. 5 , 6 ), we measured transcellular flux of fluoresceinated albumin across differentiated human podocyte monolayers on culture inserts. Infection of polarized human podocytes by SeV doubled or tripled the passage of albumin from the basolateral to the apical chamber, compared to the flux observed with cells left untreated in culture medium ( fig. 6 e) . Human podocytes also increased paracellular albumin permeability after the addition of extracellular dsRNA (TLR3 stimulation), whereas transfection with dsRNA (RLH stimulation) exerts an intermediate effect on albumin transport with considerable variability. Addition of FuGENE6 without dsRNA exerted no significant effect compared to cells incubated in medium (data not shown). None of these stimuli leads to cell death or apoptosis ( fig. 5 b) . The effects we observed are similar in magnitude and kinetics to those reported in several other systems focused on elucidating the contribution of injury to podocytes on proteinuria.
Discussion
Clinical onset of the most common form of glomerulonephritis, IgAN, is often associated with respiratory or gastrointestinal syndromes that are apparently viral infections. Moreover, exacerbations of disease in the episodic pattern of IgAN are closely associated with viral disease. Up to one third of patients with IgAN follow a clinical course of progressive loss of renal function, culminating over decades in glomerulosclerosis and endstage renal failure. Progression of IgAN to irreversible nephron loss is best predicted by the severity of proteinuria at the time of onset. Patients in whom initial proteinuria subsides are much less likely to progress to end-stage renal disease than individuals with similar initial proteinuria that persists or increases. Therefore, amelioration of proteinuria is widely considered to be a therapeutic goal.
In a murine model of IgAN induced by immunization and subsequent challenge with SeV, clinical signs of glomerulonephritis are provoked only after challenge with the infectious virus; challenge of immunized mice with inactivated SeV leads to accretions of immune complexes in glomeruli, but does not produce any measurable derangement in glomerular function, even at higher doses intended to compensate for the lack of viral replication [26] [27] [28] . Conversely, challenge of nonimmune mice with the infectious virus does not elicit nephritis. Accordingly, we hypothesized that the replication of a virus in mice with a specific antiviral immune response is required for glomerular dysfunction in this mouse model; presumably, there is synergy between the glomerular deposition of immune complexes and (glomerular or extraglomerular) innate responses to viral replication. We focused on dsRNA as an important intermediate of viral replication because other PAMPs associated with viral exposure are not limited to infectious viruses and therefore would likely be invoked subsequent to challenge with an inactivated as well as an infectious virus. This report clearly shows that innate responses to dsRNA via TLR3 or RLH signaling perturb podocyte cell function and alter podocyte marker expression levels.
Podocytes are highly specialized and terminally differentiated epithelial cells that play an essential role in glomerular ultrafiltration. Proteinuria of glomerular origin, caused by leakage of protein from the blood across the glomerular capillary wall into the urinary space, can arise from injury to glomerular endothelial cells, the glomerular basement membrane, podocytes or any combination of these structures. The stereotypical morphologic response of podocytes to injury is effacement of the glomerular foot processes, characterized by loss of interdigitation and disruption of the slit diaphragm; these changes are closely associated with clinical proteinuria [29] , and often lead to renal failure. Proteinuria cannot be determined directly at the cell culture level. Surrogates in vitro for foot process effacement or proteinuria in vivo include altered migration of cultured podocytes [30, 31] , defective expression of proteins specific to podocytes such as nephrin [23] or podocin [24] or those limited to a few cell lineages including podocytes such as CD2AP [25] , and increased transepithelial albumin flux [17, 18] . We report ( fig. 5 , 6 ) that podocytes exhibit changes in all these features in response to dsRNA or infection by SeV. These observations corroborate the principle that dsRNA can contribute to glomerular injury associated with immune complex deposition. Podocytes reside at the glomerular filtration barrier, and are subject to infection during viremia; these cells are also highly exposed to circulating viral products. Indeed, in a passive mouse model, we observed that parenteral injection of dsRNA into mice given injections of preformed IgA immune complexes intensifies proteinuria relative to animals given only the immune complexes [Inoshita et al., unpubl. data].
Whereas both TLR3 and RLH signalings reduced expression of nephrin and podocin in podocytes, only TLR3 stimulation decreased CD2AP content. Stimulation of podocytes via RLH paradoxically increased CD2AP expression. The mechanism underlying this dichotomous response is unclear at present; most intracellular signals downstream of TLR3 and RLH are common to both pathways. This antithetical response to extracellular versus intracellular dsRNA may be a linchpin for the long-term consequences of glomerular injury. Decreases in or loss of CD2AP, a scaffolding protein for dendrin, induce TGF-␤ 1-dependent translocation of dendrin from the cytosol to the nucleus, leading to cathepsin L-mediated cell injury [32] . Therefore, although RLH activation might lead to proteinuria by reducing the expression of other proteins intrinsic to the slit diaphragm, the effect of such signaling might promote the repair of podocytes by increasing CD2AP and thereby blunting cathepsin Lmediated podocyte injury. On the other hand, TLR3 activation diminishes CD2AP expression, and might favor the progression of podocyte injury to glomerulosclerosis and end-stage renal disease.
Although originally recognized as a sensor for viral dsRNA, TLR3 was recently found to detect RNA from necrotic cells as well [33] . Therefore, TLR3 might play an important role not only in glomerulonephritis associated with viral infection, but also in conjunction with necrosis associated with severe inflammation, such as the crescentic and necrotizing forms of glomerulonephritis secondary to microscopic angiitis, vasculitides and systemic lupus erythemaotosus. The potential for TLR3 signaling to suppress angiogenesis [34] might also influence the balance between the repair of glomerular capillaries and the evolution of glomerulosclerosis.
In summary, our study demonstrates that podocytes express functional TLR3 and RLH signaling pathways and that intraglomerular innate responses can contribute to glomerular dysfunction and shape the long-term consequences of podocyte injury. Deeper investigation of these effects and their potential synergy with responses to immune complexes in glomeruli might foster improved diagnosis and treatment of IgAN and other forms of glomerulonephritis.
